[1] Meyers RL, Maibach R, Hiyama E, et al.Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic Tumors International Collaboration. Lancet Oncol, 2017, 18:122-131. [2] Pugmire BS, Towbin AJ.Magnetic resonance imaging of primary pediatric liver tumors. Pediatr Radiol, 2016, 46:764-777. [3] Lopez-Terrada D, Zimmermann A.Current issues and controversies in the classification of pediatric hepatocellular tumors. Pediatr Blood Cancer, 2012, 59(5):780-784. [4] Contrast-enhanced CT features of hepatoblastoma: Can we predict histopathology Cancer Imaging, 2016,16(Suppl 1): 28. [5] Mackinlay GA, Pritchard H.A common language for child- hood liver-tumors. Pediatr Surg Int, 1992,7:325-326. [6] Towbin AJ, Meyers RL, Woodley H, et al.2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediat Radiol, 2018,56:1-19. [7] Spector LG, Birch J.The epidemiology of hepatoblastoma. Pediatr Blood Cancer, 2012, 59:776-779. [8] McCarville MB, Roebuck DJ. Diagnosis and staging of hepatoblastoma: imaging aspects. Pediatr Blood Cancer,2012, 59:793-799. [9] Ayllon TD, Gómez BO, Ciria BR, et al.Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review. World J Gastroenterol, 2014, 20(29):10137-10143. [10] Becker K, Furch C, Schmid I, et al.Impact of postoperative complications on overall survival of patients with hepatoblastoma. Pediatr Blood Cancer,2015, 62(1): 24-28. [11] Ortega JA, Douglass EC, Feusner JH, et al.Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group . J Clin Oncol, 2000, 18(14): 2665-2675. [12] Perilongo G, Shafford E, Maibach R, et al.Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer, 2004, 40:411-421. [13] Hishiki T, Matsunaga T, Sasaki F, et al.Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int, 2011, 27:1-8. [14] 赵强, 王峥, 乔晓红,等. PRETEXT术前分期在40例肝母细胞瘤手术切除中的价值分析. 中国肿瘤临床, 2011, 38(11):672-674. [15] Von Schweinitz D.Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg, 2012, 21(1):21-30. |